PPH Crosses Critical Technical Indicator

In trading on Thursday, shares of the Pharmaceutical ETF ( PPH) entered into oversold territory, changing hands as low as $58.70 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator used to measure momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In the case of Pharmaceutical, the RSI reading has hit 25.8 — by comparison, the RSI reading for the S&P 500 is currently 32.2.

START SLIDESHOW:
Find out what 9 other oversold stocks you need to know about »

A bullish investor could look at PPH's 25.8 reading as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side.

Looking at a chart of one year performance (below), PPH's low point in its 52 week range is $46.34 per share, with $62.89 as the 52 week high point — that compares with a last trade of $58.72. Pharmaceutical shares are currently trading down about 1.5% on the day.

Pharmaceutical 1 Year Performance Chart

If you liked this article you might like

5 ETFs to Buy If You Love Johnson & Johnson's First-Quarter Earnings

5 ETFs to Buy If You Love Johnson & Johnson's First-Quarter Earnings

3 Must-Watch Economic Indicators for the Summer

3 Must-Watch Economic Indicators for the Summer

The Trader Daily: Valeant's Crash Scatters Debris

The Trader Daily: Valeant's Crash Scatters Debris

Why Now May Be the Time for a Dose of Pharmaceutical Stocks

Why Now May Be the Time for a Dose of Pharmaceutical Stocks

Biotech and Pharmaceutical Stocks Look Sick, Creating Problems for Stock Market

Biotech and Pharmaceutical Stocks Look Sick, Creating Problems for Stock Market